GASTROINTESTINAL AND OTHER SELECTED ADVERSE EFFECTS OF CYCLIN-DEPENDENT KINASE 4 AND 6 INHIBITORS IN BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Shohdy, Kyrillus [2 ]
Lasheen, Shaimaa [2 ]
Kassem, Loay [2 ]
Abdel-Rahman, Omar [1 ]
机构：
[1] Ain Shams Fac Med, Dept Clin Oncol, Cairo, Egypt
[2] Kasr Alainy Sch Med, Dept Clin Oncol, Cairo, Egypt
来源：
BREAST | 2017年 / 36卷
关键词：
D O I：
10.1016/S0960-9776(17)30719-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO100
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis
    Shohdy, Kyrillus S.
    Lasheen, Shaimaa
    Kassem, Loay
    Abdel-Rahman, Omar
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (11) : 337 - 347
  • [2] Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
    Kassem, Loay
    Shohdy, Kyrillus S.
    Lasheen, Shaimaa
    Abdel-Rahman, Omar
    Bachelot, Thomas
    BREAST CANCER, 2018, 25 (01) : 17 - 27
  • [3] Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
    Loay Kassem
    Kyrillus S. Shohdy
    Shaimaa Lasheen
    Omar Abdel-Rahman
    Thomas Bachelot
    Breast Cancer, 2018, 25 : 17 - 27
  • [4] A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer
    Zhang, Jialin
    Xu, Xinyu
    Zhou, Yeyue
    Su, Jingyang
    Wang, Jue
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [5] Association between cyclin-dependent kinase 4/6 inhibitors and nephrotoxicity in patients with breast cancer: A Systematic Review and meta-analysis
    Cui, Jiayong
    Sun, Jinquan
    Zhou, Xueying
    Li, Yi
    Zhao, Jiuda
    Shen, Guoshuang
    ISCIENCE, 2024, 27 (12)
  • [6] Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
    Lasheen, Shaimaa
    Shohdy, Kyrillus S.
    Kassem, Loay
    Abdel-Rahman, Omar
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (09) : 851 - 856
  • [7] Arthralgia induced by endocrine therapy with or without cyclin-dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta-analysis
    Takatsuka, Daiki
    Sawaki, Masataka
    Hattori, Masaya
    Yoshimura, Akiyo
    Kotani, Haruru
    Kataoka, Ayumi
    Horisawa, Nanae
    Ozaki, Yuri
    Endo, Yuka
    Nozawa, Kazuki
    Iwata, Hiroji
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (05) : E175 - E182
  • [8] Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis
    Guo, Zijie
    Zhu, Ziyu
    Luo, Mingpeng
    Cao, Yijia
    Lin, Xixi
    Wu, Qingliang
    Wang, Shenkangle
    Wang, Linbo
    Zhou, Jichun
    ONCOLOGIST, 2025, 30 (02):
  • [9] Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study
    Ding, Haiying
    Xu, Weiben
    Dai, Mengfei
    Li, Shujing
    Xin, Wenxiu
    Tong, Yinghui
    He, Chaoneng
    Mi, Xiufang
    Zhan, Zhajun
    Fang, Luo
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 157 - 165
  • [10] Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer
    Fradley, Michael G.
    Nguyen, Nam H. K.
    Madnick, David
    Chen, Yiqing
    DeMichele, Angela
    Makhlin, Igor
    Dent, Susan
    Lefebvre, Benedicte
    Carver, Joseph
    Upshaw, Jenica N.
    DeRemer, David
    Ky, Bonnie
    Guha, Avirup
    Gong, Yan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (12):
12345